Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome-Reference-Cited by-同舟云学术

Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome

Published:2018-09-01 Issue:9 Volume:75 Page:1071
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Zimmermann Hanna G.¹,Knier Benjamin²³,Oberwahrenbrock Timm¹,Behrens Janina¹,Pfuhl Catherina⁴,Aly Lilian²³,Kaminski Miriam²,Hoshi Muna-Miriam²,Specovius Svenja¹,Giess René M.¹,Scheel Michael¹,Mühlau Mark²⁵,Bellmann-Strobl Judith¹⁶,Ruprecht Klemens⁴,Hemmer Bernhard²⁷,Korn Thomas²³⁷,Paul Friedemann¹⁴⁶,Brandt Alexander U.¹

Affiliation:

1. NeuroCure Clinical Research Center, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

2. Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

3. Department of Experimental Neuroimmunology, Technische Universität München, Munich, Germany

4. Department of Neurology, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

5. TUM Neuroimaging Center, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

6. Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

7. Munich Cluster of Systems Neurology (SyNergy), Munich, Germany

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Reference45 articles.

1. Multiple sclerosis.;Compston;Lancet,2008

2. Disease modifying therapies for relapsing multiple sclerosis.;Wingerchuk;BMJ,2016

3. The transition from first-line to second-line therapy in multiple sclerosis.;Dörr;Curr Treat Options Neurol,2015

4. Role of the innate and adaptive immune responses in the course of multiple sclerosis.;Hemmer;Lancet Neurol,2015

5. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.;Polman;Ann Neurol,2011

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores;Neurology Neuroimmunology & Neuroinflammation;2024-09

2. Moderne Methoden und Anwendungsgebiete der retinalen Bildgebung;Klinische Neurophysiologie;2024-09

3. Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis;Nature Communications;2024-06-19

4. The neuropathobiology of multiple sclerosis;Nature Reviews Neuroscience;2024-05-24

5. Retinal small vessel pathology is associated with disease burden in multiple sclerosis;Multiple Sclerosis Journal;2024-05-15